NeurAxis Announces Its Medical Policy Coverage Now Serves Over 26M Medical Plan Members

NeurAxis, Inc. (NYSE: NRXS) has announced new medical policy coverage for its Percutaneous Electrical Nerve Field Stimulation (PENFS) therapy from a major national health insurer. This coverage will benefit approximately 26 million medical plan members across multiple states, enhancing the company's market reach in neuromodulation therapies for chronic conditions.